查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953473

光學同調斷層掃描市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、技術、應用、地區和競爭格局分類，2021-2031年）

Optical Coherence Tomography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Technology, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球光同調斷層掃瞄（OCT）市場預計將從 2025 年的 18.8 億美元成長到 2031 年的 28.7 億美元，複合年成長率為 7.31%。

光學相干斷層掃描（OCT）是一種非侵入性診斷工具，它利用低相干干涉技術產生生物組織的高解析度截面影像，主要用於視網膜評估和冠狀動脈血管分析。市場成長趨勢主要受全球人口快速老化以及由此導致的慢性眼科疾病（如老齡化黃斑部病變和青光眼）發病率上升的推動，這些疾病需要頻繁且高精度的監測。國際防盲機構（IAPB）2024年的數據也印證了對這種可擴展診斷技術日益成長的需求。該機構預測，未來30年視力喪失可能增加55%，凸顯了先進影像診斷技術在預防失明方面的重要角色。

市場概覽
預測期 2027-2031
市場規模：2025年 18.8億美元
市場規模：2031年 28.7億美元
複合年成長率：2026-2031年 7.31%
成長最快的細分市場 頻域光學相干斷層掃描（FD-OCT）
最大的市場 北美洲

儘管臨床需求強勁，但由於這些先進系統實施和維修成本高昂，市場面臨許多障礙，阻礙了其在資源有限的醫療機構中的廣泛應用。這種經濟障礙有效地阻止了其在發展中地區和小規模獨立診所的市場滲透，因為這些診所缺乏大型醫院網路那樣雄厚的資本預算。此外，操作OCT設備並解讀其複雜數據需要專門的培訓，這造成了人才短缺，可能會延緩這些設備融入日常診療流程，而高效的患者護理在這些流程中至關重要。

市場促進因素

老齡化相關眼科疾病的日益普遍顯著增加了臨床對精準診斷影像的需求，成為全球光同調斷層掃瞄）市場的主要驅動力。隨著全球人口老化趨勢的加劇，糖尿病視網膜病變和老齡化黃斑部病變等疾病的發生率顯著上升，使得定期視網膜篩檢和早期發現至關重要。疾病發生率的增加直接推動了基層醫療和專科眼科對OCT設備的需求。例如，Eyes On Eyecare於2024年5月發表的報導「模型估計值：糖尿病視網膜病變盛行率」的文章指出，目前約有四分之一的40歲及以上糖尿病患者患有糖尿病視網膜病變，凸顯了需要定期進行OCT評估的患者數量龐大。

掃頻源和頻譜域光學相干斷層掃描（OCT）技術的突破正在消除影像解析度、速度和組織滲透性方面的傳統限制，進一步推動市場擴張。製造商正投入大量資源進行研發，以整合人工智慧（AI）和先進的視覺化功能，從而簡化臨床工作流程並提高診斷準確性。這種對創新的投入也體現在主要企業的財務策略中。例如，卡爾蔡司醫療技術股份公司（Carl Zeiss Meditec AG）於2024年12月發布的《2023/24年度報告》指出，該公司將16.6%的企業收入投入研發，以推動未來成長並保持技術優勢。這些進步增強了臨床效用，並促進了OCT技術的廣泛普及。正如SpecsAvers於2024年10月發布的《2023-24年度回顧》所示，每年進行的OCT掃描超過770萬次，證實了該技術在現代眼科中的關鍵作用。

市場挑戰

光同調斷層掃瞄）系統購買和維護所需的大量資本投入是全球市場成長的主要障礙。高昂的擁有成本實際上將開發中國家的小規模獨立診所和醫療機構拒之門外，使其無法使用這項技術，導致市場主要局限於資金雄厚的醫院網路。當診斷中心面臨嚴格的預算限制時，無論臨床上對視網膜成像的需求如何，無力投資此類資本密集型設備都會直接降低製造商的潛在市場規模。

報銷率的下降加劇了這一財務障礙，延長了這些設備的投資回收期，並阻礙了診所升級設備的動機。例如，美國眼科學會2024年報告稱，美國醫療保險和醫療補助服務中心決定將2025會計年度的醫生收費標準轉換係數降低約2.8%。營運收入的下降顯著限制了眼科診所的購買力，延緩了先進OCT系統的普及，最終減緩了市場整體擴張的步伐。

市場趨勢

家用光學相干斷層掃描（OCT）系統的興起正在改變視網膜疾病的管理模式，使診斷不再依賴集中式醫療機構。這一趨勢有助於對老齡化黃斑部病變等疾病進行常規監測，從而實現早期發現病變，而無需頻繁就診。近期，患者可控設備獲得監管部門核准，進一步增強了該模式的臨床可行性，減少了與診所監測相關的後勤挑戰。例如，NotalVision公司在2024年5月發布的題為「FDA授予NotalVision人工智慧家用OCT設備SCANLY新的上市核准」的新聞稿中指出，在一項關鍵性臨床試驗中，97%的參與者成功在家中採集了OCT影像，證實了自我成像是一種可靠的疾病進展追蹤方法。

同時，市場正拓展至介入性心臟病學領域，血管內OCT在該領域展現出優於傳統血管造影術的優勢。這項技術能夠提供血管形態的高解析度視覺化影像，使心臟病專家能夠在複雜病例中精準定位支架，從而顯著提高病患安全性。 OCT的精準度是傳統影像技術無法企及的，這項臨床優勢正推動其在導管檢查室的應用。歐洲心臟學會2024年9月發表的一篇題為「光學同調斷層掃描血管造影術方面優於傳統血管造影」的論文證實了這一優勢。論文報告稱，在OCCUPI試驗中，與血管造影術引導的手術相比，OCT引導可將不利事件的綜合風險降低38%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球光學同調斷層掃描市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（導管式OCT、多普勒OCT、手持式OCT、桌上型OCT）
    • 依技術分類（時域光學相干斷層掃描（TDOCT）、頻域光學相干斷層掃描（FD-OCT）、空間編碼頻域光學相干斷層掃描）
    • 依應用領域（眼科、循環系統、腫瘤科、皮膚科等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美光學同調斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲光學同調斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區光學同調斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲光學同調斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美光學同調斷層掃描市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球光學同調斷層掃描市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Agfa-Gevaert Group
  • Carl Zeiss Meditec AG
  • Heidelberg Engineering GmbH
  • Imalux Corp.
  • Michelson Diagnostics
  • Novacam Technologies, Inc.
  • OPTOPOL Technology SA
  • Metall Zug AG
  • Topcon Corporation
  • Thorlabs, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 21967

The Global Optical Coherence Tomography Market is projected to expand from USD 1.88 Billion in 2025 to USD 2.87 Billion by 2031, registering a CAGR of 7.31%. As a non-invasive diagnostic tool, OCT employs low-coherence interferometry to generate high-resolution, cross-sectional images of biological tissues, primarily utilized for retinal assessments and coronary vascular analysis. The market's upward trajectory is largely fueled by a rapidly aging global demographic and a corresponding increase in chronic eye conditions like age-related macular degeneration and glaucoma, which require frequent, high-precision monitoring. This growing necessity for scalable diagnostics is underscored by data from the International Agency for the Prevention of Blindness in 2024, which forecasts a potential 55 percent rise in vision loss over the next three decades, emphasizing the vital role of advanced imaging in preventing blindness.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.88 Billion
Market Size 2031USD 2.87 Billion
CAGR 2026-20317.31%
Fastest Growing SegmentFrequency Domain OCT (FD-OCT)
Largest MarketNorth America

Despite robust clinical demand, the market encounters significant hurdles due to the high costs of acquiring and maintaining these sophisticated systems, which curtails adoption in resource-limited healthcare environments. This financial obstacle effectively hinders market penetration within developing regions and smaller independent clinics that lack the substantial capital budgets found in major hospital networks. Additionally, the need for specialized training to operate OCT equipment and interpret complex data results in a workforce bottleneck, potentially delaying the integration of these devices into general practice workflows where efficient patient throughput is critical.

Market Driver

The rising prevalence of age-related ocular disorders acts as a major engine for the Global Optical Coherence Tomography Market, significantly increasing the clinical requirement for precise diagnostic imaging. With global demographics trending toward an older population, the incidence of conditions like diabetic retinopathy and age-related macular degeneration has intensified, necessitating routine retinal screening and early detection. This uptick in disease frequency directly boosts demand for OCT devices across both primary optometry and specialized ophthalmology sectors. For example, a May 2024 article by Eyes On Eyecare titled 'Modeled Estimates: Prevalence of Diabetic Retinopathy' notes that roughly one in four Americans aged 40 and older with diabetes currently suffers from diabetic retinopathy, highlighting the immense volume of patients needing regular tomographic evaluation.

Technological breakthroughs in Swept-Source and Spectral-Domain OCT are further propelling market expansion by resolving earlier constraints related to imaging resolution, speed, and tissue penetration. Manufacturers are dedicating substantial resources to research and development to incorporate artificial intelligence and advanced visualization features, which help streamline clinical workflows and enhance diagnostic precision. This dedication to innovation is reflected in the financial strategies of key industry players; for instance, Carl Zeiss Meditec AG's 'Annual Report 2023/24' from December 2024 reveals the company invested 16.6 percent of its revenue into R&D to foster future growth and technological distinction. Such advancements improve clinical utility and facilitate widespread adoption, as evidenced by Specsavers' 'Annual Review 2023-24' from October 2024, which reported over 7.7 million OCT scans performed during the year, confirming the technology's essential place in modern eye care.

Market Challenge

The significant capital expenditure needed to purchase and maintain Optical Coherence Tomography systems constitutes a major impediment to global market growth. High ownership costs effectively exclude smaller independent clinics and healthcare facilities in developing nations from accessing the technology, confining the market largely to well-endowed hospital networks. When diagnostic centers operate under strict budgetary constraints, their inability to invest in such capital-intensive equipment directly shrinks the Total Addressable Market for manufacturers, irrespective of the clinical need for retinal imaging.

This financial hurdle is intensified by falling reimbursement rates, which prolong the Return on Investment period for these devices and dissuade practice owners from upgrading their equipment. For example, the American Academy of Ophthalmology reported in 2024 that the Centers for Medicare & Medicaid Services finalized a reduction of roughly 2.8 percent in the physician fee schedule conversion factor for the 2025 calendar year. Such decreases in operational revenue severely limit the purchasing power of ophthalmology practices, forcing them to delay acquiring advanced OCT systems and thereby slowing the overall pace of market expansion.

Market Trends

The rise of home-based OCT systems is transforming retinal disease management by shifting diagnostic care away from centralized facilities. This trend facilitates daily monitoring of conditions such as neovascular age-related macular degeneration, enabling the early detection of pathology without the need for frequent office visits. The clinical viability of this model was reinforced by recent regulatory approvals for patient-operated devices, which mitigate the logistical challenges of in-office monitoring. Highlighting the practicality of these platforms, a May 2024 press release from Notal Vision titled 'FDA Grants AI-Powered Notal Vision Home OCT "SCANLY" De Novo Marketing Authorization' reported that pivotal trials found 97 percent of participants successfully captured OCT images at home, establishing self-imaging as a dependable method for longitudinal disease tracking.

Concurrently, the market is extending into interventional cardiology, where intravascular OCT is demonstrating superiority over standard angiography. By offering high-resolution visualization of vessel morphology, this technology allows cardiologists to refine stent deployment in complex cases, leading to significantly improved patient safety. This clinical advantage is fueling adoption in catheterization laboratories by providing a level of precision that traditional imaging cannot achieve. Demonstrating this benefit, the European Society of Cardiology's September 2024 article 'Optical coherence tomography outperforms conventional angiography for stent guidance in complex cases' noted that the OCCUPI trial showed OCT guidance lowered the combined risk of adverse cardiovascular events by 38 percent compared to angiography-guided procedures.

Key Market Players

  • Agfa - Gevaert Group
  • Carl Zeiss Meditec AG
  • Heidelberg Engineering GmbH
  • Imalux Corp.
  • Michelson Diagnostics
  • Novacam Technologies, Inc.
  • OPTOPOL Technology S.A.
  • Metall Zug AG
  • Topcon Corporation
  • Thorlabs, Inc

Report Scope

In this report, the Global Optical Coherence Tomography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Optical Coherence Tomography Market, By Type

  • Catheter based OCT Devices
  • Doppler OCT Devices
  • Handheld OCT Devices
  • Tabletop OCT Devices

Optical Coherence Tomography Market, By Technology

  • Time Domain OCT (TDOCT)
  • Frequency Domain OCT (FD-OCT)
  • Spatial Encoded Frequency Domain OCT

Optical Coherence Tomography Market, By Application

  • Ophthalmology
  • Cardiovascular
  • Oncology
  • Dermatology
  • Others

Optical Coherence Tomography Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Optical Coherence Tomography Market.

Available Customizations:

Global Optical Coherence Tomography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Optical Coherence Tomography Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Catheter based OCT Devices, Doppler OCT Devices, Handheld OCT Devices, Tabletop OCT Devices)
    • 5.2.2. By Technology (Time Domain OCT (TDOCT), Frequency Domain OCT (FD-OCT), Spatial Encoded Frequency Domain OCT)
    • 5.2.3. By Application (Ophthalmology, Cardiovascular, Oncology, Dermatology, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Optical Coherence Tomography Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Optical Coherence Tomography Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Optical Coherence Tomography Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Optical Coherence Tomography Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application

7. Europe Optical Coherence Tomography Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Optical Coherence Tomography Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
    • 7.3.2. France Optical Coherence Tomography Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Optical Coherence Tomography Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Optical Coherence Tomography Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Optical Coherence Tomography Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application

8. Asia Pacific Optical Coherence Tomography Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Optical Coherence Tomography Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
    • 8.3.2. India Optical Coherence Tomography Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Optical Coherence Tomography Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Optical Coherence Tomography Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Optical Coherence Tomography Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application

9. Middle East & Africa Optical Coherence Tomography Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Optical Coherence Tomography Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Optical Coherence Tomography Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Optical Coherence Tomography Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application

10. South America Optical Coherence Tomography Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Optical Coherence Tomography Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Optical Coherence Tomography Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Optical Coherence Tomography Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Optical Coherence Tomography Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Agfa - Gevaert Group
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Carl Zeiss Meditec AG
  • 15.3. Heidelberg Engineering GmbH
  • 15.4. Imalux Corp.
  • 15.5. Michelson Diagnostics
  • 15.6. Novacam Technologies, Inc.
  • 15.7. OPTOPOL Technology S.A.
  • 15.8. Metall Zug AG
  • 15.9. Topcon Corporation
  • 15.10. Thorlabs, Inc

16. Strategic Recommendations

17. About Us & Disclaimer